1. Home
  2. JXG vs SEER Comparison

JXG vs SEER Comparison

Compare JXG & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JX Luxventure Limited

JXG

JX Luxventure Limited

SELL

Current Price

$7.75

Market Cap

103.6M

Sector

N/A

ML Signal

SELL

Logo Seer Inc.

SEER

Seer Inc.

SELL

Current Price

$2.12

Market Cap

108.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
JXG
SEER
Founded
N/A
2017
Country
China
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.6M
108.0M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
JXG
SEER
Price
$7.75
$2.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.5K
★ 297.3K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 9.40
EPS
★ N/A
N/A
Revenue
N/A
★ $16,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$20.50
P/E Ratio
$0.77
★ N/A
Revenue Growth
N/A
★ 16.99
52 Week Low
$0.23
$1.55
52 Week High
$12.00
$2.41

Technical Indicators

Market Signals
Indicator
JXG
SEER
Relative Strength Index (RSI) 50.89 53.76
Support Level $7.37 $1.70
Resistance Level $8.37 $2.30
Average True Range (ATR) 0.99 0.11
MACD 0.04 0.01
Stochastic Oscillator 61.20 57.98

Price Performance

Historical Comparison
JXG
SEER

About JXG JX Luxventure Limited

JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products. The Company's operations are located in the PRC and all of the Company's revenue is derived from sales to customers in the PRC region.

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Share on Social Networks: